Literature DB >> 7871573

Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation.

G Hotter1, D Closa, F Pi, N Prats, L Fernandez-Cruz, O Bulbena, E Gelpí, J Roselló-Catafau.   

Abstract

The role of eicosanoid metabolism and its relationship with nitric oxide production in the ischemia-reperfusion associated with pancreas transplantation in the rat is explored in this study. Twenty-six male Sprague-Dawley rats were randomized into 3 groups, as follows: group 1, control animals not surgically manipulated; group 2, pancreas transplantation, after 12 hr of organ preservation in University of Wisconsin solution; group 3, same as group 2 but with administration of NG-nitro-L-arginine methyl ester (a nitric oxide synthase inhibitor) (10 mg/kg) before organ revascularization. The results show posttransplantation increases in edema and in 6-keto-prostaglandin F1 alpha (x1.9), thromboxane B2 (x4), and prostaglandin E2 (x5) levels in pancreatic tissue. Nitric oxide synthase inhibition reversed the increases in edema and eicosanoid production, which suggests that eicosanoid generation in the recipient rat would be mediated, in part, through a nitric oxide-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7871573

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

Review 1.  Free radicals and the pancreatic acinar cells: role in physiology and pathology.

Authors:  M Chvanov; O H Petersen; A Tepikin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

2.  Endothelin mediated nitric oxide effects in ischemia--reperfusion associated with pancreas transplantation.

Authors:  G Hotter; F Pi; C Sanz; C Peralta; N Prats; E Gelpi; F Badosa; L Fernández-Cruz; J Roselló-Catafau
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

3.  Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection.

Authors:  J Such; D J Hillebrand; C Guarner; L Berk; P Zapater; J Westengard; C Peralta; G Soriano; J Pappas; B A Runyon
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

4.  Nitric oxide enhances 12-HETE versus LTB4 generation in pancreatic transplantation.

Authors:  G Hotter; D Closa; F Pí; L Fernández-Cruz; E Gelpí; J Roselló-Catafau
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

5.  Differential effect of nitric oxide inhibition as a function of preservation period in pancreas transplantation.

Authors:  F Pi; G Hotter; D Closa; N Prats; L Fernández-Cruz; F Badosa; E Gelpi; J Roselló-Catafau
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

6.  Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.

Authors:  M Sàbat; C Guarner; G Soriano; O Bulbena; M T Novella; J Ortiz; E Ricart; C Villanueva; J Rosello; J Rodríguez; J Balanzó
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

7.  Protective role of nitric oxide in ischemia and reperfusion injury of the liver.

Authors:  T Shimamura; Y Zhu; S Zhang; M B Jin; N Ishizaki; A Urakami; E Totsuka; A Kishida; R Lee; V Subbotin; H Furukawa; T E Starzl; S Todo
Journal:  J Am Coll Surg       Date:  1999-01       Impact factor: 6.113

8.  Prevention of lethal murine pancreas ischemia reperfusion injury is specific for tetrahydrobiopterin.

Authors:  Manuel Maglione; Benno Cardini; Rupert Oberhuber; Katrin Watschinger; Marcel Jenny; Johanna Gostner; Martin Hermann; Peter Obrist; Raimund Margreiter; Johann Pratschke; Gerald Brandacher; Ernst R Werner
Journal:  Transpl Int       Date:  2012-07-17       Impact factor: 3.782

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.